These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23236087)

  • 1. Relative efficacy of cash versus vouchers in engaging opioid substitution treatment clients in survey-based research.
    Topp L; Islam MM; Day CA
    J Med Ethics; 2013 Apr; 39(4):253-6. PubMed ID: 23236087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-perceived problem with alcohol use among opioid substitution treatment clients.
    Islam MM; Day CA; Conigrave KM; Topp L
    Addict Behav; 2013 Apr; 38(4):2018-21. PubMed ID: 23384455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion.
    Festinger DS; Marlowe DB; Dugosh KL; Croft JR; Arabia PL
    Drug Alcohol Depend; 2008 Jul; 96(1-2):128-35. PubMed ID: 18395365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cash value of voucher reinforcers in pregnant drug-dependent women.
    Rosado J; Sigmon SC; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):41-7. PubMed ID: 15727502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual versus team-based case-management for clients of opioid treatment services: an initial evaluation of what clients prefer.
    Day CA; Demirkol A; Tynan M; Curry K; Hines S; Lintzeris N; Haber PS
    Drug Alcohol Rev; 2012 Jun; 31(4):499-506. PubMed ID: 21919976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation in payments to research subjects.
    Phillips T
    Bioethics; 2011 May; 25(4):209-19. PubMed ID: 19438444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
    Winstock AR; Lea T; Sheridan J
    Addiction; 2010 Feb; 105(2):335-42. PubMed ID: 20078490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TANF/SSI connection.
    Wamhoff S; Wiseman M
    Soc Secur Bull; 2005-2006; 66(4):21-36. PubMed ID: 17590982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability benefit coverage and program interactions in the working-age population.
    Rupp K; Davies PS; Strand A
    Soc Secur Bull; 2008; 68(1):1-30. PubMed ID: 18837269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do research payments precipitate drug use or coerce participation?
    Festinger DS; Marlowe DB; Croft JR; Dugosh KL; Mastro NK; Lee PA; Dematteo DS; Patapis NS
    Drug Alcohol Depend; 2005 Jun; 78(3):275-81. PubMed ID: 15893158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative valuation placed by children and teenagers on participation in two hypothetical research scenarios.
    Funnell D; Fertleman C; Carrey L; Brierley J
    J Med Ethics; 2012 Nov; 38(11):686-91. PubMed ID: 22815539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
    Treloar C; Hull P; Dore GJ; Grebely J
    Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR; Lea T; Sheridan J
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
    Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
    Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs.
    Park JN; White B; Bates A; Enriquez J; Liao L; Maher L
    Drug Alcohol Depend; 2012 Jun; 123(1-3):35-40. PubMed ID: 22071117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planned duration of residential drug abuse treatment: efficacy versus effectiveness.
    McCusker J; Bigelow C; Vickers-Lahti M; Spotts D; Garfield F; Frost R
    Addiction; 1997 Nov; 92(11):1467-78. PubMed ID: 9519490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recreational drug use: patterns from a South Wales self-report survey.
    Wadsworth EJ; Simpson SA; Moss SC; Smith AP
    J Psychopharmacol; 2004 Jun; 18(2):228-37. PubMed ID: 15260912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanguard contraceptive users subject of Senegal research.
    Netw Res Triangle Park N C; 1985; 6(2):5-7. PubMed ID: 12266648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.